227 related articles for article (PubMed ID: 17116693)
1. Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction.
Goruppi S; Patten RD; Force T; Kyriakis JM
Mol Cell Biol; 2007 Feb; 27(3):993-1006. PubMed ID: 17116693
[TBL] [Abstract][Full Text] [Related]
2. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
[TBL] [Abstract][Full Text] [Related]
3. Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8.
Georgescu SP; Aronovitz MJ; Iovanna JL; Patten RD; Kyriakis JM; Goruppi S
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1046-56. PubMed ID: 21775709
[TBL] [Abstract][Full Text] [Related]
4. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
5. The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4.
Goruppi S; Kyriakis JM
J Biol Chem; 2004 May; 279(20):20950-8. PubMed ID: 15016802
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the transcriptional regulator p8 results in increased autophagy and apoptosis, and causes impaired heart function.
Kong DK; Georgescu SP; Cano C; Aronovitz MJ; Iovanna JL; Patten RD; Kyriakis JM; Goruppi S
Mol Biol Cell; 2010 Apr; 21(8):1335-49. PubMed ID: 20181828
[TBL] [Abstract][Full Text] [Related]
7. Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine.
Omura T; Yoshiyama M; Yoshida K; Nakamura Y; Kim S; Iwao H; Takeuchi K; Yoshikawa J
Hypertension; 2002 Jan; 39(1):81-6. PubMed ID: 11799083
[TBL] [Abstract][Full Text] [Related]
8. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
Bergman MR; Cheng S; Honbo N; Piacentini L; Karliner JS; Lovett DH
Biochem J; 2003 Feb; 369(Pt 3):485-96. PubMed ID: 12371906
[TBL] [Abstract][Full Text] [Related]
9. Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism.
Kathiriya IS; King IN; Murakami M; Nakagawa M; Astle JM; Gardner KA; Gerard RD; Olson EN; Srivastava D; Nakagawa O
J Biol Chem; 2004 Dec; 279(52):54937-43. PubMed ID: 15485867
[TBL] [Abstract][Full Text] [Related]
10. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
[TBL] [Abstract][Full Text] [Related]
11. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy.
Goruppi S; Bonventre JV; Kyriakis JM
EMBO J; 2002 Oct; 21(20):5427-36. PubMed ID: 12374743
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor.
Thomas WG; Brandenburger Y; Autelitano DJ; Pham T; Qian H; Hannan RD
Circ Res; 2002 Feb; 90(2):135-42. PubMed ID: 11834705
[TBL] [Abstract][Full Text] [Related]
14. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
[TBL] [Abstract][Full Text] [Related]
16. The role of endothelin-converting enzyme-1 in the development of alpha1-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes.
Kaburagi S; Hasegawa K; Morimoto T; Araki M; Sawamura T; Masaki T; Sasayama S
Circulation; 1999 Jan; 99(2):292-8. PubMed ID: 9892597
[TBL] [Abstract][Full Text] [Related]
17. Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro.
Busk PK; Wulf-Andersen L; Strøm CC; Enevoldsen M; Thirstrup K; Haunsø S; Sheikh SP
Exp Cell Res; 2003 May; 286(1):102-14. PubMed ID: 12729799
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro.
Autelitano DJ; Ridings R; Tang F
Cardiovasc Res; 2001 Aug; 51(2):255-64. PubMed ID: 11470465
[TBL] [Abstract][Full Text] [Related]
19. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
